Cannabis Care Needs Evidence and Respect for the Plant
{ "@context": "https://schema.org", "@type": [ "Article", "MedicalWebPage" ], "headline": "Cannabis Care Needs Evidence and Respect for the Plant", "articleBody":…
When Experience and Evidence Pull You Apart
{ "@context": "https://schema.org", "@type": [ "Article", "MedicalWebPage" ], "headline": "When Experience and Evidence Pull You Apart", "articleBody": "A patient’s…
“Dosing by Guesswork vs. Science: The Cannabis Conundrum”
Dr. Caplan’s Clinical Pearl When patients rely on eyeballing random flower for cannabis dosing, it's not uncommon to see inconsistent results and unpredictable side effects. This approach can be especially problematic for those with complex medical…
Using Cannabis to Cut Back on Alcohol? Your Working Memory Might Dictate If It Works
Cannabis substitution cognitive function plays a key role in reducing alcohol consumption. Working memory capacity may predict who benefits most from cannabis-assisted alcohol reduction. This insight supports personalized cannabis substitution strategies.
How Pharmacogenomics Genetic Variants Influence GLP-1 Therapy
Pharmacogenomics genetic variants play a key role in modulating response to GLP-1 receptor agonists. These variants can affect both weight loss efficacy and side effect profiles, especially nausea with tirzepatide. Understanding these genetic factors…
Dr. Sanjay Gupta Reports: Why More Women are Turning to Medical Cannabis for Healing
Women medical cannabis use is growing rapidly, especially for chronic pain and anxiety. Hormonal interactions affect how women respond to cannabis treatment. Understanding these patterns helps tailor personalized therapies for female patients.
GLP-1 Receptor Agonist Results: Why Genetics Matter
Pharmacogenomic variability in GLP-1 receptor agonist response influences how patients experience weight loss and glycemic control. Genetic differences can explain why some patients respond differently to treatment. Understanding this variability helps…
GLP-1 Receptor Agonist Response: What Genetics Reveals
Pharmacogenomic variation in GLP-1 receptor signaling plays a crucial role in how patients respond to GLP-1 receptor agonists like semaglutide and tirzepatide. This genetic influence explains differences in glycemic and weight loss outcomes.…
How Genetic Predictors Influence GLP-1 Receptor Agonist Efficacy
Genetic predictors GLP-1 efficacy explain why patients respond differently to GLP-1 receptor agonists in weight loss therapy. Understanding these genetic factors helps clinicians tailor treatments. This insight supports precision medicine in obesity care.
GLP-1 Receptor Agonist Response: How Genes Shape Outcomes
Pharmacogenomics drug response variability plays a key role in how patients respond to GLP-1 receptor agonists. Genetic differences can affect both weight loss outcomes and side effect profiles. Understanding these variations supports personalized…
